Literature DB >> 17299491

Metabolic syndrome and ADRB3 gene polymorphism in severely obese patients from South Italy.

R Bracale1, F Pasanisi, G Labruna, C Finelli, C Nardelli, P Buono, G Salvatori, L Sacchetti, F Contaldo, G Oriani.   

Abstract

OBJECTIVE: To evaluate the prevalence of beta(3)-adrenergic receptor (ADRB3) Trp64Arg polymorphism and its relationship with the metabolic syndrome in severe obesity.
DESIGN: Cross-sectional outpatients study. PATIENTS AND METHODS: In 265 (100 men) severely obese non-diabetic subjects and 78 (25 men) healthy volunteers, genomic DNA was isolated from peripheral leukocytes. In obese patients, plasma concentrations of leptin, lipids, glucose and insulin, the homeostasis model assessment index and blood pressure have been measured. The Trp64Arg mutation was identified with the real-time TaqMan method.
RESULTS: Neither genotype distribution nor allele frequency differed between the two groups. The metabolic syndrome prevalence was 59% in obese subjects, and was higher in men than in women (65 vs 55%: P=0.03). The body mass index (BMI) was related to age tertiles (beta=0.08; P<0.001; multiple linear regression) in Trp64Arg-positive obese subjects.
CONCLUSION: We confirm the high prevalence of the metabolic syndrome among severely obese subjects. ADRB3 polymorphism was significantly related to insulin resistance only in obese male subjects. Moreover, increased BMI was related to age in obese subjects with the ADRB3 polymorphism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299491     DOI: 10.1038/sj.ejcn.1602640

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  5 in total

1.  The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance.

Authors:  R Bracale; G Labruna; C Finelli; A Daniele; L Sacchetti; G Oriani; F Contaldo; F Pasanisi
Journal:  J Endocrinol Invest       Date:  2012-01       Impact factor: 4.256

2.  Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population.

Authors:  Rajani Rai; Kiran L Sharma; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-21       Impact factor: 4.553

3.  Metabolic and nutritional status changes after 10% weight loss in severely obese patients treated with laparoscopic surgery vs integrated medical treatment.

Authors:  Federica del Genio; Lucia Alfonsi; Maurizio Marra; Carmine Finelli; Gianmattia del Genio; Gianluca Rossetti; Alberto del Genio; Franco Contaldo; Fabrizio Pasanisi
Journal:  Obes Surg       Date:  2007-11-14       Impact factor: 4.129

4.  ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.

Authors:  Maha Daghestani; Mazin Daghestani; Mamoon Daghistani; Abdelmoneim Eldali; Zeinab K Hassan; Maha H Elamin; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

5.  Activation of the adipocyte CREB/CRTC pathway in obesity.

Authors:  Young-Sil Yoon; Weiyi Liu; Sam Van de Velde; Shigenobu Matsumura; Ezra Wiater; Ling Huang; Marc Montminy
Journal:  Commun Biol       Date:  2021-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.